| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |